12 / 136
AfroCentric INTEGRATED ANNUAL REPORT 2016
10
W.B. Holdings (cash shell on the JSE)
Sanlam acquired 28.7% of ACT
Healthcare Assets, a major
subsidiary of AfroCentric
AfroCentric was awarded the
Polmed Scheme contract
AfroCentric acquired 100% of
Pharmacy Direct, 100% of Curasana
and 26% of Activo Health
AfroCentric Health Limited, the largest
operational subsidiary of the Group, repurchased its outstanding
5.9% minority interest. AfroCentric Health Limited became
a private company effective July 2016 and is now called
AfroCentric Health (Pty) Limited (“AHL”)
AfroCentric increased its
shareholding to 94.1% in AHL
AfroCentric is born (80% of share
capital purchased) and listed
on the JSE
AfroCentric purchased the AHL Group (80% shareholding)
AfroCentric acquired the South
African licence of the DBC back and
neck rehabilitation programme
2016
2014
2010
2008
COMPANY HISTORY
A 51% interest in Allegra was acquired by Helios IT Solutions
2012
2009
2005